Form 8-K - Current report:
SEC Accession No. 0001829126-26-001748
Filing Date
2026-02-27
Accepted
2026-02-27 16:45:32
Documents
16
Period of Report
2026-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K voyageracq_8k.htm   iXBRL 8-K 53770
2 EXHIBIT 99.1 voyageracq_ex99-1.htm EX-99.1 32275
3 GRAPHIC ex99-1_001.jpg GRAPHIC 81392
4 GRAPHIC ex99-1_002.jpg GRAPHIC 934
  Complete submission text file 0001829126-26-001748.txt   425939

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vachu-20260227.xsd EX-101.SCH 4203
6 XBRL DEFINITION FILE vachu-20260227_def.xml EX-101.DEF 27366
7 XBRL LABEL FILE vachu-20260227_lab.xml EX-101.LAB 38050
8 XBRL PRESENTATION FILE vachu-20260227_pre.xml EX-101.PRE 25986
18 EXTRACTED XBRL INSTANCE DOCUMENT voyageracq_8k_htm.xml XML 7020
Mailing Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002
Business Address C/O WINSTON & STRAWN LLP 800 CAPITOL ST., STE 2400 HOUSTON TX 77002 03477204333
Voyager Acquisition Corp./Cayman Islands (Filer) CIK: 0002006815 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42211 | Film No.: 26701058
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)